Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: A phase IV, randomized, open-label, controlled study

Published 2015 View Full Article

Authors

Keywords

AS03, H5N1 vaccine, Pandemic influenza, Korean adults

Journal

VACCINE

Volume 33, Issue 24, Pages 2800-2807

Publisher

Elsevier BV

Online

2015-04-22

DOI

10.1016/j.vaccine.2015.04.027

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started